Detalhe da pesquisa
1.
Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib.
Blood
; 138(26): 2810-2827, 2021 12 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34407545
2.
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.
Blood
; 137(10): 1365-1376, 2021 03 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32992344
3.
Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration.
Clin Chem
; 62(1): 243-51, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26430073
4.
A rare case of selective Igκ chain deficiency: Biologic and clinical implications.
J Allergy Clin Immunol
; 146(5): 1208-1210.e6, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32278584
5.
Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies.
J Proteome Res
; 14(4): 1957-67, 2015 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-25734799
6.
Monitoring M-proteins in patients with multiple myeloma using heavy-chain variable region clonotypic peptides and LC-MS/MS.
J Proteome Res
; 13(4): 1905-10, 2014 Apr 04.
Artigo
Inglês
| MEDLINE | ID: mdl-24552626
7.
Phenotyping polyclonal kappa and lambda light chain molecular mass distributions in patient serum using mass spectrometry.
J Proteome Res
; 13(11): 5198-205, 2014 Nov 07.
Artigo
Inglês
| MEDLINE | ID: mdl-25134970
8.
Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.
Br J Haematol
; 163(3): 326-33, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24032430
9.
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.
Cancer Immunol Res
; 11(9): 1222-1236, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37378662
10.
Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.
Blood
; 116(16): 2984-93, 2010 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-20606160
11.
LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis.
Blood
; 116(16): 2975-83, 2010 Oct 21.
Artigo
Inglês
| MEDLINE | ID: mdl-20595513
12.
Stage-Specific Non-Coding RNA Expression Patterns during In Vitro Human B Cell Differentiation into Antibody Secreting Plasma Cells.
Noncoding RNA
; 8(1)2022 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35202088
13.
Extracellular vesicle proteomic analysis leads to the discovery of HDGF as a new factor in multiple myeloma biology.
Blood Adv
; 6(11): 3458-3471, 2022 06 14.
Artigo
Inglês
| MEDLINE | ID: mdl-35395072
14.
B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells.
Blood Cancer J
; 12(7): 99, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35778390
15.
Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients.
J Clin Invest
; 118(1): 306-15, 2008 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-18064298
16.
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab.
Blood
; 113(3): 535-7, 2009 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-19008456
17.
Biologic and genetic characterization of the novel amyloidogenic lambda light chain-secreting human cell lines, ALMC-1 and ALMC-2.
Blood
; 112(5): 1931-41, 2008 Sep 01.
Artigo
Inglês
| MEDLINE | ID: mdl-18567838
18.
Role of long non-coding RNAs in disease progression of early stage unmutated chronic lymphocytic leukemia.
Oncotarget
; 10(1): 60-75, 2019 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30713603
19.
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Br J Haematol
; 141(5): 615-21, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18373706
20.
CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.
Br J Haematol
; 140(5): 537-46, 2008 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-18275431